Relative Lipophilicities, Solubilities, and Structure–Pharmacological Considerations of 3-Hydroxy-3-Methylglutaryl-Coenzyme A (HMG-CoA) Reductase Inhibitors Pravastatin, Lovastatin, Mevastatin, and Simvastatin-Reference-Cited by-同舟云学术

Relative Lipophilicities, Solubilities, and Structure–Pharmacological Considerations of 3-Hydroxy-3-Methylglutaryl-Coenzyme A (HMG-CoA) Reductase Inhibitors Pravastatin, Lovastatin, Mevastatin, and Simvastatin

Published:1991-09 Issue:9 Volume:80 Page:830-834
ISSN:0022-3549
Container-title:Journal of Pharmaceutical Sciences
language:en
Short-container-title:Journal of Pharmaceutical Sciences

Author:

Serajuddin Abu T.M.,Ranadive Sunanda A.,Mahoney Eileen M.

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference24 articles.

1. Reduction of Serum Cholesterol in Heterozygous Patients with Familial Hypercholesterolemia

2. The Effect of CS-514 on Serum Lipids and Apolipoproteins in Hypercholesterolemic Subjects

3. 3-Hydroxy-3-Methylglutaryl—Coenzyme A Reductase Inhibitors in the Treatment of Hypercholesterolemia

4. HMG-CoA Reductase Inhibitors for Treatment of Hypercholesterolemia

5. Lovastatin

Cited by 192 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Co-milling of β-cyclodextrin with simvastatin: Solid state studies and dissolution profile;Journal of Drug Delivery Science and Technology;2023-11

2. Evidence of Strong Guest–Host Interactions in Simvastatin Loaded in Mesoporous Silica MCM-41;Pharmaceutics;2023-04-22

3. Use of an Uncertainty Profile to Validate High-Performance Liquid Chromatography (HPLC) for the Simultaneous Determination of Statins in Synthetic Pharmaceutical Products;Analytical Letters;2023-02-14

4. Smith-Lemli-Opitz syndrome: A pathophysiological manifestation of the Bloch hypothesis;Frontiers in Molecular Biosciences;2023-01-12

5. Nutraceutical Approaches to Dyslipidaemia: The Main Formulative Issues Preventing Efficacy;Nutrients;2022-11-11